Recently, China shocked the world by announcing its approval of the first commercially used brain chip in the world to treat paralysis, placing the country at the forefront of technological innovations in this area. The chip, designed by 'Neuralke Medical Technology', is named 'Niu' and enables individuals suffering from paralysis due to neck or spinal cord injuries to control the movement of their hands through thought.
This approval comes after 18 months of trials that confirmed the safety of the treatment. Evidence shows that the chip, which is implanted in the skull and is about the size of a coin, contains eight electrodes directly connected to the brain areas responsible for controlling movements in various parts of the body.
Once the user thinks of moving their hand, the chip sends a signal to a computer, which translates that signal into commands that move prosthetic limbs. This technology also allows users to take advantage of mechanical gloves capable of performing simple tasks, such as picking up objects and manipulating eating utensils.
Despite several companies worldwide working on developing brain chip implantation technologies, none have yet obtained marketing approval for their innovations as treatment practices. Even advanced projects like 'Neuralink' have faced challenges leading to delays in regulatory approvals.
In this context, the development of the market is at the forefront, as the Chinese government issued a policy document several months ago outlining a strategy to create a competitive industry in the field of brain-computer interfaces over the next five years. This document includes 17 steps aimed at promoting research, development, and application of these technologies. Experts point out that the Chinese government has always supported innovative technologies, considering that these policies indicate a shift for brain interface technology from the concept stage to product stage.
The plan includes boosting the production of non-invasive devices applicable in various fields, such as forehead or ear-mounted devices like hearing aids and glasses. The testing of these inventions is also suggested in high-risk sectors such as handling hazardous materials and nuclear energy.
So far, brain implants have focused on a primary goal: restoring autonomy for disabled individuals. There are experimental devices that enable interaction using thoughts, running computers without moving muscles, and represent programs that restore vision. With the commercial approval of 'Niu', a new era of brain chip implantation industry begins.
This development represents a sign of rapid advancement in the medical field, where technological innovations have already transformed traditional treatments, contributing to enhancing the quality of life for individuals with disabilities.
However, the transition from laboratory research to marketable products opens discussions about the ethics associated with this technology, such as privacy and control over thoughts. How will the use of this technology affect different societies, and what regulations are necessary to ensure its ethical uses?
This significant technological development highlights the importance of translational medical research and reflects the global race towards innovation in medicine. Although there are challenges facing these technologies, the move towards achieving autonomy for individuals with special needs will open new horizons for techniques that can revolutionize various fields.
In the Middle East, these developments may garner significant interest, especially with the increasing focus on medical technologies and scientific research. Supporting research in this field could enhance healthcare for individuals with disabilities, leading to the development of local solutions tailored to the culture and specific needs of the region.